Completed
Sunitinib in Metastatic Renal Cancer
NCT01034878
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Istituto Clinco Humanitas Rozzano, Milano, Italy
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT01131234
- Conditions
- Adenocarcinoma, Adnexal Diseases, Adult Anaplastic Astrocytoma, +120 more
- Locations
-
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
NCT00253383
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anus Diseases, +75 more
- Locations
-
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
- Veterans Affairs Medical Center - White River Junction White River Junction, Vermont, United States
NCT00044564
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- La Jolla, California, United States
- Muncie, Indiana, United States
- New Orleans, Louisiana, United States
- Baltimore, Maryland, United States
NCT00079612
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Chicago, Illinois, United States
- Philadelphia, Pennsylvania, United States
- Houston, Texas, United States
- San Antonio, Texas, United States
NCT01015911
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center / University of California at Los Angeles Los Angeles, California, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
NCT00117637
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Sacramento, California, United States
- Aurora, Colorado, United States
- Chicago, Illinois, United States
- Frederick, Maryland, United States
NCT00520403
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Berlin, Germany
- Berlin, Germany
- Bremen, Germany
- Dessau, Germany
Completed
Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)
NCT00570882
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Daegu Catholic University Hospital Daegu, South Korea
- Yeungnam University Medical Center Daegu, South Korea
- Asan Medical Center Seoul, South Korea
NCT02247583
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Katholieke Universiteit Leuven - Klinische Farmacologie en Farmacotherapie Leuven, Belgium